Insmed (INSM) EBT Margin (2010 - 2026)
Insmed's (INSM) quarterly EBT Margin came in at 52.98% in Q1 2026, up 22246.0% year-on-year from N/an in Q1 2025, and up 57.24% quarter-over-quarter from 123.91% in Q4 2025.
Insmed (INSM) EBT Margin (2010 - 2026) Analysis & Trends
Insmed's EBT Margin history runs 12 years deep, the most recent figure standing at 52.98% for Q1 2026.
- On a quarterly basis, EBT Margin rose 22246.0% year-over-year to 52.98% in Q1 2026; TTM through Mar 2026 was 143.76%, a 12111.0% increase from a year earlier, with the FY2025 full-year figure at 209.71%, up 4051.0% from the prior year.
- EBT Margin advanced to 52.98% in Q1 2026 per INSM's latest filing, from 123.91% in the prior quarter.
- Across five years, EBT Margin topped out at 52.98% in Q1 2026 and bottomed at 331.83% in Q2 2024.
- The 5-year median for EBT Margin is 224.32% (2024), against an average of 222.13%.
- Across the five-year window, EBT Margin sank 17043 bps in 2023 and soared 22246 bps in 2026, its largest moves.
- Year by year, EBT Margin stood at 269.81% in 2022, then grew by 18 bps to 221.12% in 2023, then fell by 1 bps to 224.32% in 2024, then jumped by 45 bps to 123.91% in 2025, then soared by 57 bps to 52.98% in 2026.
- Per Business Quant, the three latest INSM EBT Margin figures stand at 52.98% (Q1 2026), 123.91% (Q4 2025), and 259.02% (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 17.13% |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 41.95% |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 23.05% |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 34.77% |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Insmed | 23.26 Bn | 22.03 Bn | 258.54 Mn | -52.98% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -52.98% |
| Dec 31, 2025 | -123.91% |
| Sep 30, 2025 | -259.02% |
| Jun 30, 2025 | -298.32% |
| Mar 31, 2025 | -275.44% |
| Dec 31, 2024 | -224.32% |
| Sep 30, 2024 | -234.96% |
| Jun 30, 2024 | -331.83% |
| Mar 31, 2024 | -207.29% |
| Dec 31, 2023 | -221.12% |
| Sep 30, 2023 | -200.31% |
| Jun 30, 2023 | -316.30% |
| Mar 31, 2023 | -244.24% |
| Dec 31, 2022 | -269.81% |
| Sep 30, 2022 | -193.08% |
| Jun 30, 2022 | -145.88% |
| Mar 31, 2022 | -177.45% |
| Dec 31, 2021 | -201.37% |
| Sep 30, 2021 | -246.58% |
| Jun 30, 2021 | -257.24% |